Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conserved structural features between HLA-DO beta and -DR beta

J Thibodeau1, P M Lavoie, A Samaan

  • 1Immunochimie Analytique, Institut Pasteur, Paris, France. thibodj@magellan.umontreal.ca

Molecular Immunology
|December 5, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel paradigm enables accurate monthly gestational screening to prevent congenital toxoplasmosis and more.

medRxiv : the preprint server for health sciences·2023
Same author

Polycomb contraction differentially regulates terminal human hematopoietic differentiation programs.

BMC biology·2022
Same author

The Crohn's disease-associated polymorphism in ATG16L1 (rs2241880) reduces SHIP gene expression and activity in human subjects.

Genes and immunity·2015
Same author

Catecholamine-resistant hypotension and myocardial performance following patent ductus arteriosus ligation.

Journal of perinatology : official journal of the California Perinatal Association·2014
Same author

Design and implementation of a randomized crossover study of valproic acid and antiretroviral therapy to reduce the HIV reservoir.

HIV clinical trials·2012
Same author

Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2012
Same journal

m6A modification of LINC00458 enhances HMOX1 stability via ELAVL1 recruitment to promote ferroptosis and aggravate asthma.

Molecular immunology·2026
Same journal

Overexpression of Hes1 inhibits cigarette smoke-induced mitochondrial apoptosis in AT2 cells by activating the Pgc-1α/Tfam signaling pathway.

Molecular immunology·2026
Same journal

Progesterone promotes favorable pregnancy outcomes in recurrent spontaneous, abortion by attenuating NK Cell overactivation and upregulating the cAMP/PKA/CREB signaling axis.

Molecular immunology·2026
Same journal

Oleanolic acid alleviates hepatic fibrosis by inhibiting liver macrophage recruitment and polarization.

Molecular immunology·2026
Same journal

Cordycepin attenuates diabetic nephropathy by dual-pathway activation of TFEB to restore autophagy and ameliorate podocyte injury.

Molecular immunology·2026
Same journal

Endothelial-derived TWEAK drives granulosa cell apoptosis in PCOS via the Fn14-oxidative stress axis.

Molecular immunology·2026
See all related articles

Human Leukocyte Antigen-DO (HLA-DO) beta-chain shares structural similarities with HLA-DR beta. This structural conservation suggests conserved functions in antigen presentation and T cell interactions.

Area of Science:

  • Immunology
  • Structural Biology
  • Molecular Genetics

Background:

  • Human Leukocyte Antigen-DO (HLA-DO) is a non-classical MHC class II molecule.
  • Its precise function in antigen processing remains largely unelucidated.

Purpose of the Study:

  • To model the structure of the HLA-DO beta-chain.
  • To investigate the functional similarities between HLA-DO beta and other MHC class II beta-chains, particularly HLA-DR beta.
  • To explore the implications of structural conservation for HLA-DO's in vivo functions.

Main Methods:

  • Computational modeling of the HLA-DO beta-chain structure.
  • Functional assays using mixed heterodimers of DR alpha and chimeric DO beta-chains.
  • Assessment of T cell presentation of bacterial superantigens.

Related Experiment Videos

  • Evaluation of CD4 interaction with the presented heterodimers.

    • Main Results:

    • The modeled HLA-DO beta-chain exhibits structural compatibility with the HLA-DR beta chain.
    • Mixed heterodimers (DR alpha/chimeric DO beta) successfully presented bacterial superantigens to T cells.
    • These heterodimers demonstrated interaction with CD4, a key co-receptor in T cell activation.

    Conclusions:

    • Structural similarities between HLA-DO beta and HLA-DR beta suggest conserved molecular mechanisms.
    • HLA-DO beta can form functional heterodimers capable of antigen presentation and CD4 interaction.
    • Further research is warranted to fully understand the in vivo roles of HLA-DO in immune responses.